Orthostatic hypotension and heart rate variability as indicators of cardiac autonomic neuropathy in diabetes mellitus

European Journal of General Medicine

Volumn 2, Issue 1, 2005, Pages 5-9

  Koçer, Abdülkadir ^a,e   Aktürk, Zekeriya ^c   Maden, Emin ^d   Taşçi, Atilla ^b  

^a PTT Hospital   (Turkey)

^b Department of Internal Medicine ^*  (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d SSK Sureyyapasa Center for Chest Diseases and Thoracic Surgery   (Turkey)

^e Namik Kemal Mah   (Turkey)

Author keywords

Autonomic neuropathy; Diabetes; HbA1c; Heart rate variability; Orthostatic hypotension; QT interval

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MONITORING; BODY POSTURE; BREATHING; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; QT PROLONGATION;

EID: 33646576322     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993;10(9):820
2. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhytmias. In: Zipes DP, Jalife I, eds. Cardiac Electrophysiology. From cell to bedside. Philadelphia: W.B. Saunders 1990:330
3. Oka H, Mochio S, Sato K et al. Prolongation of QTc interval and nervous dysfunction in diabetic patients. Diabetes Res Clin Pract 1996;31(1-3):63-70
4. Kumhar MR, Agarval TD, Singh VB, Kochar DK, Chadda VS. Cardiac autonomic neuropathy and its correlation with QTc dispersion in type 2 diabetes. Indian Heart J 2000;52(4):421-6
5. Lo ss, Sutton MS, Leslie RD. Information on type I diabetes mellitus and QT interval from identical twins. Am J Cardiol 1993;72(3):305-9
6. Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 1991;46(2):189-200
7. Katsuoka H, Mimori Y, Kurokawa K et al. QTc interval, and autonomic and somatic nerve function in diabetic neuropathy. Clin Auton Res 1998;8(3):139-43
8. Task Force of the European Society of Cardiology and the North American Society of pacing and Electrophysiology: Heart rate variability-standars of measurement, physiological interpretation, and clinical use. European Heart Journal 1996;17: 354-81
9. Aytemir K, Aksoyek S, Özeer N, Gürlek A, Oto A. QT dispersion and autonomic nervous system function in patients with type I diabetes. Int J Cardiol 1998;65(1): 45-50
10. Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A, Kastrup J, Parving HH. Prolonged QTc interval predicts mortality in patients with Type I diabetes mellitus. Diabet Med 2001;18(3): 199-205
11. Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patient: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care 2000;23(9):1381-3
12. Veglio M, Chinaglia A, Borra M, Perin PC. Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients QTc interval measure versus standardized tests in diabetic autonomic neuropathy. Diyabet Med 1995;12(4): 302-6
13. Tentolouris N, Katsilambros N, Papzachos G et al. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy. Eur J Clin Invest 1997;27(12): 1049-54
14. Bloom A, Ireland J, Watkins P. Autonomic Neuropathy. Nervous System. In: A colour atlas of diabetes. Wolfe Publishing Ltd. Second Edition. Spain 1992:98
15. Purewal TS, Watkins PJ. Postural hypotension in diabetic autonomic neuropathy a review. Diabet Med 1995;12(3):192-200